|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$50,176.35 |
2.69% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$49,219.50 |
2.64% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$48,492.06 |
2.60% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$47,165.41 |
2.53% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$45,627.66 |
2.44% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$44,496.58 |
2.38% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$44,116.80 |
2.36% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$43,800.00 |
2.35% |
| Waters Corporation |
WAT |
941848103 |
123 |
$43,719.12 |
2.34% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$43,454.52 |
2.33% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$42,164.00 |
2.26% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$41,770.24 |
2.24% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$41,486.08 |
2.22% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$41,422.57 |
2.22% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$41,332.16 |
2.21% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$39,824.04 |
2.13% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$39,167.82 |
2.10% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$39,164.22 |
2.10% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$38,919.03 |
2.08% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$38,718.72 |
2.07% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,746.80 |
2.02% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$37,358.93 |
2.00% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$37,213.96 |
1.99% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$37,123.34 |
1.99% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$36,714.90 |
1.97% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$36,802.73 |
1.97% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$36,704.19 |
1.97% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$36,674.19 |
1.96% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$36,382.32 |
1.95% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$35,782.34 |
1.92% |
| Steris Plc |
STE |
G8473T100 |
177 |
$35,861.97 |
1.92% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$35,704.80 |
1.91% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$35,389.86 |
1.89% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$35,033.21 |
1.88% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$35,041.65 |
1.88% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$34,656.72 |
1.86% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$34,465.05 |
1.85% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$34,345.20 |
1.84% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$34,269.23 |
1.83% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$33,837.53 |
1.81% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$33,135.42 |
1.77% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$32,842.10 |
1.76% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$32,501.99 |
1.74% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$32,444.36 |
1.74% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$32,224.85 |
1.73% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$29,152.00 |
1.56% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$28,793.76 |
1.54% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$28,849.73 |
1.54% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$25,894.46 |
1.39% |
| US Dollar |
$USD |
|
9,852 |
$9,852.08 |
0.53% |
| Japanese Yen |
$JPY |
|
91,571 |
$567.36 |
0.03% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|